Albendazole therapy for subarachnoid and ventricular cysticercosis. Case report.
Medical or surgical therapy for subarachnoid or ventricular cysticercosis is a controversial issue. The authors report a patient with cysticercus larvae in both ventricular and subarachnoid locations, who was successfully treated with albendazole. Thus, medical therapy has a role in the treatment of these forms of neurocysticercosis.
del Brutto
O H
OH
Research Division, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.
Sotelo
J
J
D000328:Adult; D015766:Albendazole / Q000627:therapeutic use*; D001927:Brain Diseases / Q000188:drug therapy / Q000469:parasitology; D002552:Cerebral Ventricles / Q000469:parasitology*; D014695:Cerebral Ventriculography; D003551:Cysticercosis / Q000188:drug therapy* / Q000469:parasitology; D005260:Female; D006801:Humans; D013346:Subarachnoid Space / Q000000981:diagnostic imaging / Q000469:parasitology*; D014057:Tomography, X-Ray Computed
D015766:Albendazole